Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Oragenics stock in Canada | $0.54

Own Oragenics shares in just a few minutes.

Updated . What changed?

Fact checked

Oragenics, Inc is a biotechnology business based in the US. Oragenics shares (OGEN.US) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.54 – a decrease of 1.82% over the previous week. Oragenics employs 7 staff and has a market cap (total outstanding shares value) of $24 million.

How to buy shares in Oragenics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: OGEN in this case.
  5. Research Oragenics shares. The platform should provide the latest information available.
  6. Buy your Oragenics shares. It's that simple.

How has Coronavirus impacted Oragenics's share price?

Since the stock market crash in March caused by coronavirus, Oragenics's share price has had significant negative movement.

Its last market close was $0.54, which is 11.48% down on its pre-crash value of $0.61 and 22.73% up on the lowest point reached during the March crash when the shares fell as low as $0.44.

If you had bought $1,000 worth of Oragenics shares at the start of February 2020, those shares would have been worth $1,227.27 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,227.27.

Oragenics share price

Use our graph to track the performance of OGEN stocks over time.

Oragenics shares at a glance

Information last updated 2020-11-25.
Latest market close $0.54
52-week range $0.36 - $2.09
50-day moving average $0.5125
200-day moving average $0.7027
Wall St. target price $2.5
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.511

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
Buy and sell thousands of US and Canadian stocks and ETFs commission-free with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are equal to or greater than US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$4.95 - $9.95
$9.95 + $1 per contract
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
CI Direct Investing (formerly WealthBar)
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Automatic bank withdrawals
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).
Direct deposit, Bank transfer, Automatic bank withdrawals
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Wealthsimple Invest
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Minimum US$25
Shares Desktop, Web Trading, Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on

Compare up to 4 providers

Is it a good time to buy Oragenics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Oragenics price performance over time

Historical closes compared with the last close of $0.54

1 week (2020-11-24) 38.46%
1 month (2020-11-02) 9.49%
3 months (2020-09-02) -18.18%
6 months (2020-06-02) -2.81%
1 year (2019-11-29) -12.90%
2 years (2018-11-30) -60.00%
3 years (2017-12-01) 28.57%
5 years (2015-12-01) -63.51%

Oragenics financials

Gross profit TTM USD$0
Return on assets TTM -92.15%
Return on equity TTM -168.22%
Profit margin 0%
Book value $0.04
Market capitalisation USD$24 million

TTM: trailing 12 months

How to short and sell Oragenics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "OGEN.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.1 million Oragenics shares held short by investors – that's known as Oragenics's "short interest". This figure is 31.3% down from 1.6 million last month.

There are a few different ways that this level of interest in shorting Oragenics shares can be evaluated.

Oragenics's "short interest ratio" (SIR)

Oragenics's "short interest ratio" (SIR) is the quantity of Oragenics shares currently shorted divided by the average quantity of Oragenics shares traded daily (recently around 2.5 million). Oragenics's SIR currently stands at 0.42. In other words for every 100,000 Oragenics shares traded daily on the market, roughly 420 shares are currently held short.

However Oragenics's short interest can also be evaluated against the total number of Oragenics shares, or, against the total number of tradable Oragenics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Oragenics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Oragenics shares in existence, roughly 20 shares are currently held short) or 0.0215% of the tradable shares (for every 100,000 tradable Oragenics shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Oragenics.

Find out more about how you can short Oragenics stock.

Oragenics share dividends

We're not expecting Oragenics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Oragenics's shares ever split?

Oragenics's shares were split on a 1:10 basis on 22 January 2018. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Oragenics shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Oragenics shares which in turn could have impacted Oragenics's share price.

Oragenics share price volatility

Over the last 12 months, Oragenics's shares have ranged in value from as little as $0.36 up to $2.09. A popular way to gauge a stock's volatility is its "beta".

OGEN.US volatility(beta: 0.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Oragenics's is 0.7497. This would suggest that Oragenics's shares are less volatile than average (for this exchange).

Oragenics overview

Oragenics, Inc. develops novel antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring compound for use in weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against dental caries, or tooth decay. Oragenics, Inc. has collaboration agreements with Precigen, Inc. and its subsidiary, Intrexon Actobiotics NV to develop AG013; and a license agreement with LPThera LLC to develop LPT3-04. It also has a process development and drug substance manufacturing agreement with Avid Bioservices, Inc. for coronavirus vaccine. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site